A recent study demonstrated that IL-13 can induce an aggressive type of colorectal cancer by enhancing the expression of the epithelial–mesenchymal transition-promoting factor ZEB1 through the STAT6-dependent pathway [14]. This evidence concerns the gene ZEB1 and colorectal cancer.